22
Feb
2010
Posted in I - Series A, Q - 1Q10, R - MID WEST, X - BPH, X - Device (Ablation), X - Histotripsy, XX - MI
HistoSonics (Ann Arbor, MI) a development stage device company focused on non-invasive image-guided tissue ablation for benign prostatic hyperplasia, closed an $11M Series A financing. Participants include Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.
11
Feb
2010